Distribution en place
- Germany
- Austria
- Italy (Genomica Lab)
- Switzerland (Labor Team W)
- United Kingdom(Tdl Pathology)
- Sweden (Life Genomics)
- Lithuania (Placenta)
- United Arab Emirates (Cureleads)
- Finland ( Life Genomics)
- Norway ( Life Genomics)
- Saudi Arabia
- Denmark ( Life Genomics)
- Estonia
- Latvia
- Israel (Tzamal)
- Iceland ( Life Genomics)
- Hungary ( Gén Diagnosztika)
Partenariat engagé
- Australia
- Belgium
- Canada
- France
- Greece
- New Zealand
- Poland
- Portugal
- Spain
- USA
Ziwig Endotest®, a simple and non-invasive test, which allows for the early detection of all types of endometriosis with a performance that exceeds that of conventional diagnostic tests1-6 (sensitivity >95%, specificity >95%, diagnostic accuracy AUC of >95%)7. Ziwig Endotest® is a breakthrough innovation that will enable early care and significantly improve patient’s quality of life thanks to the reliable, rapid and non-invasive diagnosis of endometriosis. Ziwig Endotest® is already available in some countries via local distributors and partners who aim to provide all women suspected of endometriosis the possibility of doing the test.
Ziwig Endotest® has obtained the CE label and is subject to medical prescription.
1 – Machine learning algorithms as new screening approach for patients with endometriosis. Bendifallah S & al. Sci Rep. 2022 Jan 12;12(1):639. doi: 10.1038/s41598-021-04637-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755739/pdf/41598_2021_Article_4637.pdf
2 – Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression. Dabi Y & al. Diagnostics (Basel). 2022 Jan 12;12(1):175. doi: 10.3390/diagnostics12010175. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774370/pdf/diagnostics-12-00175.pdf
3 – Salivary MicroRNA Signature for Diagnosis of Endometriosis. Bendifallah & al. J Clin Med. 2022 Jan 26;11(3):612. doi: 10.3390/jcm11030612. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836532/pdf/jcm-11-00612.pdf
4 – MicroRNome analysis generates a blood-based signature for endometriosis. Bendifallah S & al. Sci Rep. 2022 Mar 8;12(1):4051. doi: 10.1038/s41598-022-07771-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902281/pdf/41598_2022_Article_7771.pdf
5 – Endometriosis Associated-miRNome Analysis of Blood Samples: A Prospective Study. Bendifallah S & al. Diagnostics. 2022; 12(5):1150. https://doi.org/10.3390/diagnostics12051150
6 – A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis. Bendifallah S & al. Int. J. Mol. 2022, 23, 8045. https://doi.org/10.3390/ijms23148045
7 – Bendifallah, Sofiane et al. “Validation of a Salivary miRNA Signature of Endometriosis — Interim Data” NEJM Evidence. 09 June. 2023. doi: 10.1056/EVIDoa2200282
Find all our scientific publications here.
Ziwig Endotest® is an in vitro diagnostic device reserved exclusively for professional use for the diagnosis of endometriosis on salivary samples. Ziwig Endotest® is an innovative diagnostic method based on the analysis of salivary miRNAs and the identification of phenotypic profiles characteristic of endometriosis identified by NGS (Next Generation Sequencing) method and modeled by AI. Read carefully the information provided with Ziwig Endotest®. Manufacturer: Ziwig. Update: 10/2023.
Stay connected
Sign up to be notified of the latest news and publications.